P511 Baseline characteristics of ulcerative colitis patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (01)

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2017-02, Vol.11 (suppl_1), p.S339-S340
Main Authors: Wolf, D., Lewis, J.D., Siegmund, B., Lichtenstein, G., Sebastian, S., Siegel, C.A., Louis, E., Haas, T., Nedd, K., Subramanian, S., Aguilar, H., Egan, L., Gasche, C., Doherty, G., Lobo, A., Spearman, D., Patel, A., Moparty, R., Brookes, M., Hebuterne, X., Moum, B., Dolin, P.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1873-9946
1876-4479
DOI:10.1093/ecco-jcc/jjx002.635